Compare KBSX & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KBSX | NTRB |
|---|---|---|
| Founded | 1976 | 2016 |
| Country | Taiwan | United States |
| Employees | 394 | N/A |
| Industry | Recreational Games/Products/Toys | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.0M | 71.7M |
| IPO Year | N/A | N/A |
| Metric | KBSX | NTRB |
|---|---|---|
| Price | $1.38 | $4.46 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 7.6K | ★ 23.0K |
| Earning Date | 11-19-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $44,890,395.00 | $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.46 | 12.69 |
| 52 Week Low | $1.26 | $3.72 |
| 52 Week High | $15.48 | $11.78 |
| Indicator | KBSX | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 40.13 | 34.93 |
| Support Level | $1.31 | $4.60 |
| Resistance Level | $1.60 | $5.45 |
| Average True Range (ATR) | 0.04 | 0.39 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 21.15 | 15.66 |
FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.